dc.contributor.author | Holvik, Kristin | |
dc.contributor.author | Frøyland, Livar | |
dc.contributor.author | Haugen, Margaretha | |
dc.contributor.author | Løvik, Martinus | |
dc.contributor.author | Strand, Tor A | |
dc.contributor.author | Tell, Grethe S. | |
dc.contributor.author | Iversen, Per Ole | |
dc.date.accessioned | 2017-10-20T08:09:50Z | |
dc.date.available | 2017-10-20T08:09:50Z | |
dc.date.created | 2017-10-19T10:09:10Z | |
dc.date.issued | 2016 | |
dc.identifier.isbn | 978-82-8259-193-5 | |
dc.identifier.uri | http://hdl.handle.net/11250/2461187 | |
dc.description.abstract | The Norwegian Scientific Committee for Food Safety (VKM) has, at the request of the Norwegian Food Safety Authority, assessed the risk of specified doses of L-tryptophan in food supplements. VKM concludes that the specified doses 250 mg/day, 300 mg/day, and 450 mg/day tryptophan may represent a risk of adverse health effects in adults (≥18 years), adolescents (14 to <18 years), and children (10 to <14 years). | nb_NO |
dc.language.iso | eng | nb_NO |
dc.publisher | Norwegian Committee for Food Safety (VKM) | nb_NO |
dc.relation.ispartof | VKM Report | |
dc.relation.ispartofseries | VKM Report; | |
dc.relation.uri | https://vkm.no/download/18.645b840415d03a2fe8f2602c/1502802082645/cc084e11fc.pdf | |
dc.title | Risk assessment of "other substances" – L-tryptophan. Opinion of the Panel on Nutrition, Dietetic Products, Novel Food and Allergy of the Norwegian Scientific Committee for Food Safety | nb_NO |
dc.type | Research report | nb_NO |
dc.description.version | publishedVersion | nb_NO |
dc.source.pagenumber | 44 | nb_NO |
dc.source.issue | 2016: 04 | nb_NO |
dc.identifier.cristin | 1505803 | |
cristin.unitcode | 194,65,15,0 | |
cristin.unitname | Institutt for klinisk og molekylær medisin | |
cristin.ispublished | true | |
cristin.fulltext | original | |